Ad hoc announcement pursuant to Art. 53 LR
Zur Rose Group AG / Key word(s): Strategic Company Decision
Frauenfeld, 4 May 2023
Zur Rose Group has successfully completed the sale of its Swiss business to Migros
The Zur Rose Group has successfully completed the sale of its Swiss business to the Migros subsidiary Medbase today. As the new owner of the Zur Rose Switzerland business, Medbase is taking over all the Zur Rose Group's operational units in Switzerland (excluding land and properties) with all employees.
In view of the future strategic focus on the B2C core business, the Board of Directors proposes to today's Annual General Meeting to rename Zur Rose Group AG to DocMorris AG. With DocMorris – Germany's best-known health platform – the Group is strongly positioned in Germany and other European countries.
Investors and analyst contact
Zur Rose Group
End of Inside Information
|Company:||Zur Rose Group AG|
|Phone:||+41 52 724 08 14|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1624557|
|End of Announcement||EQS News Service|
1624557 04-May-2023 CET/CEST